Pseudouridylation: RPUSD4 catalyzes the conversion of uridine to pseudouridine in mitochondrial RNAs. Key targets include:
Essentiality: RPUSD4 depletion causes:
Mitochondrial Matrix: RPUSD4 localizes to mitochondrial RNA granules (MRGs), interacting with other pseudouridine synthases (TRUB2, RPUSD3) and regulatory proteins (NGRN, FASTKD2) .
Western Blotting:
Immunoprecipitation:
Immunofluorescence:
RPUSD4 is an RNA pseudouridylate synthase domain-containing protein that catalyzes the isomerization of uridine to pseudouridine in various mitochondrial RNA substrates. It plays a crucial role in several aspects of mitochondrial RNA processing:
It modifies position 1397 in 16S mitochondrial ribosomal RNA (16S mt-rRNA), which is essential for the assembly of functional mitochondrial ribosomes .
It functions as a component of a protein-RNA module (alongside RCC1L, NGRN, RPUSD3, TRUB2, FASTKD2, and 16S mt-rRNA) that controls 16S mt-rRNA abundance and is required for intra-mitochondrial translation .
It also participates in nuclear mRNA pseudouridylation, regulating pre-mRNA splicing and 3'-end processing .
RPUSD4 is considered an essential gene in human cells, as complete knockout attempts have proven unsuccessful, suggesting its fundamental importance to cellular function .
Based on current research tools, there are two main types of RPUSD4 antibodies available:
Recombinant Monoclonal Antibodies: These are typically rabbit-derived antibodies suitable for immunocytochemistry/immunofluorescence (ICC/IF), western blotting (WB), and immunoprecipitation (IP). These have been validated for human and rat samples .
Polyclonal Antibodies: These antibodies are generally used for western blot applications and have reactivity against human, mouse, and rat samples. They are typically generated using recombinant fusion proteins containing amino acid sequences from human RPUSD4 .
Both types of antibodies serve different research purposes, with monoclonal antibodies offering higher specificity and reproducibility, while polyclonal antibodies may provide better sensitivity for detecting native proteins.
RPUSD4 antibodies have been validated for several important molecular and cellular techniques:
Western Blotting (WB): Both monoclonal and polyclonal antibodies can be used at dilutions ranging from 1:200 to 1:2000 to detect RPUSD4 in cell lysates .
Immunocytochemistry/Immunofluorescence (ICC/IF): Particularly useful for localization studies showing RPUSD4's association with mitochondrial RNA granules .
Immunoprecipitation (IP): Used to pull down RPUSD4 and identify its interacting partners .
Subcellular Fractionation: While not directly using antibodies, this technique is often paired with western blotting to confirm RPUSD4's mitochondrial localization .
When combining these methods, researchers can comprehensively study both the expression levels and functional interactions of RPUSD4 in various cellular contexts.
For optimal western blot results with RPUSD4 antibodies, the following protocol has been experimentally validated:
Sample Preparation: Extract proteins from cell lines using standard lysis buffers. Load approximately 25 μg of protein per lane for clear detection .
Antibody Dilutions:
Blocking Conditions: Use 3% nonfat dry milk in TBST for optimal blocking .
Detection Method: ECL Basic Kit provides sufficient sensitivity for detection .
Exposure Time: Approximately 90 seconds is typically adequate for visualizing bands .
The expected molecular weight of RPUSD4 protein is approximately 40-45 kDa, though this may vary slightly depending on post-translational modifications or splice variants.
To confirm antibody specificity, researchers should implement multiple validation approaches:
Knockdown/Knockout Controls: Use RPUSD4-silenced cells as negative controls. Complete knockout has proven difficult, suggesting RPUSD4 is essential, but shRNA-mediated knockdown achieving approximately 80% reduction has been successful and can serve as a partial negative control .
Subcellular Fractionation: Since RPUSD4 is predominantly localized to mitochondria, fractionation studies can confirm antibody specificity by showing enrichment in mitochondrial fractions .
Antibody Validation Experiments:
Western blot analysis across multiple cell lines to verify consistent banding patterns
Peptide competition assays
Comparison of results from different antibody clones targeting different epitopes
Cross-Reactivity Assessment: Test the antibody against related pseudouridine synthases (like RPUSD3 or TRUB2) to ensure specificity within this protein family .
When designing immunofluorescence experiments to study RPUSD4:
Co-localization Markers:
Fixation Method:
Paraformaldehyde fixation (4%) is generally recommended
Avoid methanol fixation which may disrupt mitochondrial membrane structures
Permeabilization:
Use 0.2-0.5% Triton X-100 to ensure antibody access to mitochondrial matrix proteins
Controls:
Include cells with RPUSD4 knockdown to validate specificity
Use proper negative controls (secondary antibody only)
Resolution Requirements:
Super-resolution microscopy may be necessary to precisely localize RPUSD4 within mitochondrial substructures like RNA granules
RPUSD4 plays a critical role in mitochondrial ribosome assembly, particularly affecting the large subunit (mt-LSU). To investigate this:
Ribosomal Protein Analysis: Use RPUSD4 antibodies in western blotting alongside antibodies against mitoribosomal proteins (MRPs) including:
mt-LSU proteins: MRPL45, MRPL11, MRPL3, and MRPL24
mt-SSU proteins: DAP3 and MRPS27
This approach can reveal the specific impact of RPUSD4 disruption on ribosomal subunit composition .
Sucrose Gradient Analysis: Combine with western blotting to separate and analyze intact ribosomes versus individual subunits in cells with normal or depleted RPUSD4.
RNA-Protein Interaction Studies: Use techniques like RIP (RNA immunoprecipitation) with RPUSD4 antibodies to capture and identify associated RNAs, particularly 16S mt-rRNA.
Complementation Experiments: In RPUSD4-depleted cells, reintroduce wild-type or catalytically inactive RPUSD4 to determine if ribosome assembly defects can be rescued.
Research has shown that RPUSD4 depletion leads to a marked reduction in mt-LSU proteins while mt-SSU proteins remain largely unaffected, indicating its specific role in large subunit assembly .
To investigate RPUSD4's pseudouridylation activity:
CMC-Based Pseudouridine Detection:
Treat RNA with N-cyclohexyl-N′-(2-morpholinoethyl)carbodiimide (CMC)
Perform primer extension or next-generation sequencing to identify pseudouridine sites
Compare results between control and RPUSD4-depleted cells to identify RPUSD4-dependent modifications
Mass Spectrometry Analysis:
Digest RNA samples and analyze by LC-MS/MS
Quantify pseudouridine content in specific RNA species
In Vitro Reconstitution:
Express and purify recombinant RPUSD4
Perform in vitro pseudouridylation assays with synthetic RNA substrates
Confirm activity on position 1397 in 16S mt-rRNA and position 39 in mt-tRNA(Phe)
Structure-Function Analysis:
Create point mutations in catalytic domains
Use RPUSD4 antibodies to confirm expression of mutant proteins
Assess pseudouridylation activity and mitochondrial function with each mutant
Evidence indicates that RPUSD4 specifically modifies position 1397 in 16S mt-rRNA and position 39 in mt-tRNA(Phe), with these modifications being essential for proper mitochondrial translation .
RPUSD4 functions within a protein module including several other factors. To study these interactions:
Co-Immunoprecipitation (Co-IP):
Use RPUSD4 antibodies to pull down protein complexes
Identify interacting partners by western blot or mass spectrometry
Reciprocal Co-IPs with antibodies against suspected partners can confirm interactions
Proximity Labeling Techniques:
Microscopy-Based Interaction Analysis:
Fluorescence resonance energy transfer (FRET)
Proximity ligation assay (PLA)
Co-localization studies with super-resolution microscopy
Previous studies have identified a functional module consisting of RCC1L, NGRN, RPUSD3, RPUSD4, TRUB2, and FASTKD2 that controls 16S mt-rRNA abundance . The table below summarizes key interaction partners of RPUSD4:
Several factors can contribute to inconsistent western blot results when using RPUSD4 antibodies:
Sample Preparation Issues:
Incomplete extraction of mitochondrial proteins due to inadequate lysis conditions
Protein degradation during sample handling
Loss of mitochondrial fraction during cell fractionation
Technical Considerations:
Antibody dilution too high or too low (optimize between 1:200-1:2000)
Insufficient blocking leading to background signals
Inappropriate secondary antibody concentration
Biological Variables:
Cell type-specific expression levels of RPUSD4
Changes in RPUSD4 expression under different cellular conditions (stress, differentiation, etc.)
Post-translational modifications affecting antibody recognition
Solution Approaches:
For detection of low-abundance RPUSD4:
Sample Enrichment Strategies:
Isolate mitochondrial fractions to concentrate the target protein
Use immunoprecipitation to enrich RPUSD4 before western blotting
Consider using larger amounts of starting material (50-100 μg protein instead of standard 25 μg)
Signal Enhancement Methods:
Utilize high-sensitivity ECL substrates
Employ signal amplification systems (e.g., tyramide signal amplification for immunofluorescence)
Consider longer exposure times balanced against background increase
Alternative Detection Approaches:
Use mass spectrometry-based targeted proteomics (PRM or MRM) for quantitative detection
Consider RT-qPCR to measure RPUSD4 mRNA as a proxy for protein abundance
Validation Strategy:
Use genetically modified cells with tagged RPUSD4 as positive controls
Include RPUSD4-depleted samples as negative controls to confirm antibody specificity
When designing RPUSD4 knockdown experiments:
Knockdown Approach Selection:
Validation Parameters:
Phenotypic Analysis:
Assess changes in 16S mt-rRNA levels by northern blot or qRT-PCR
Measure mitochondrial translation by pulse labeling with [35S]methionine/cysteine
Evaluate respiratory complex subunit levels by western blot
Rescue Experiments:
Introduce shRNA-resistant RPUSD4 to verify phenotype specificity
Test catalytically inactive mutants to distinguish structural vs. enzymatic functions
Studies have shown that RPUSD4 depletion leads to decreased OXPHOS activity, reduced mitochondrial translation, and specific reduction of 39S mt-LSU proteins without affecting 28S mt-SSU proteins .
Recent findings indicate that RPUSD4 also functions in the nucleus to regulate pre-mRNA splicing through pseudouridylation. To investigate this:
Nuclear-Cytoplasmic Fractionation:
Use RPUSD4 antibodies to detect the protein in nuclear fractions
Compare nuclear vs. mitochondrial distribution under different cellular conditions
RNA-Protein Interaction Studies:
CLIP-seq (Crosslinking and immunoprecipitation followed by sequencing) using RPUSD4 antibodies to identify nuclear RNA targets
Compare results with mitochondrial targets to understand substrate specificity
Splicing Analysis:
RNA-seq in control vs. RPUSD4-depleted cells to identify affected splice sites
Minigene reporter assays to confirm direct effects on alternative splicing
Nuclear Localization Studies:
High-resolution imaging with RPUSD4 antibodies and nuclear markers
Analysis of potential nuclear localization signals within RPUSD4 sequence
The nuclear function of RPUSD4 in regulating pre-mRNA splicing and 3'-end processing through pseudouridylation near splice sites represents an emerging area of research .
Given RPUSD4's essential role in mitochondrial function, investigating its connection to mitochondrial diseases is valuable:
Patient Sample Analysis:
Use RPUSD4 antibodies to assess protein levels in patient-derived cells with mitochondrial diseases
Compare pseudouridylation patterns in control vs. patient samples
Disease Model Development:
Create cellular models with tissue-specific or inducible RPUSD4 depletion
Investigate phenotypes relevant to mitochondrial diseases (e.g., neurodegeneration, myopathy)
Therapeutic Screening:
Test compounds that might restore pseudouridylation or bypass the need for specific modifications
Use RPUSD4 antibodies to monitor protein levels during treatment
Biomarker Potential:
Evaluate if RPUSD4 or its RNA targets could serve as biomarkers for mitochondrial dysfunction
Develop sensitive assays for detecting RPUSD4-dependent RNA modifications
Since RPUSD4 is essential for mitochondrial translation and OXPHOS function, its dysfunction could potentially contribute to mitochondrial disease presentations, though direct links remain to be established.
To place RPUSD4 in the context of mitochondrial RNA modifications:
Comprehensive Modification Mapping:
Use antibody-based enrichment followed by sequencing to map all pseudouridylation sites
Compare with other RNA modifications (methylation, acetylation) to build a complete picture
Functional Interplay Analysis:
Study interactions between RPUSD4 and other RNA modification enzymes
Investigate whether modifications occur in a specific sequence or influence each other
Evolutionary Conservation Studies:
Compare RPUSD4-mediated modifications across species using antibody-based detection
Identify conserved vs. species-specific targets to understand evolutionary importance
Systems Biology Approach:
Create network models integrating RPUSD4 with other mitochondrial RNA processing pathways
Use protein interaction data from antibody-based pulldowns to inform these models
RPUSD4 functions within a module containing other pseudouridine synthases (RPUSD3, TRUB2) and RNA processing factors, suggesting coordinated control of mitochondrial RNA modifications .